Format

Send to

Choose Destination
Immunity. 2018 Feb 20;48(2):190-192. doi: 10.1016/j.immuni.2018.02.005.

Infants Harness the Germline against RSV.

Author information

1
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia. Electronic address: annette.fox@unimelb.au.
2
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia. Electronic address: kanta.subbarao@influenzacentre.org.
3
WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, VIC, Australia; Department of Microbiology and Immunology, The University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.

Abstract

In this issue of Immunity, Goodwin et al. (2018) offer hope for an RSV vaccine for young infants by demonstrating that RSV infection in very young infants induces neutralizing antibodies that are close to the germline and have unusual epitope specificity.

PMID:
29466748
DOI:
10.1016/j.immuni.2018.02.005
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center